Monday, October 5, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Ursa Brown-Glaberman, MD

Ursa Brown-Glaberman, MD

medical oncologist

Ursa Brown-Glaberman, MD, is a medical oncologist at CHRISTUS St. Vincent Regional Cancer Center, where she serves as director of research. Before joining CHRISTUS St. Vincent in 2025, she spent 11 years at the University of New Mexico Comprehensive Cancer Center in multiple leadership roles. Throughout her career, she has focused on engaging community oncology colleagues and patients in clinical research, and her current role is centered on expanding clinical trial opportunities for cancer patients across northern New Mexico.

Published Articles (1)

Combining Immunotherapy With Local Treatment Advances Liver Cancer Care, While a Provocative New Question Emerges About Diabetes Drugs

October 4, 2026

For more than two decades, transarterial chemoembolization (TACE) has been the standard of care for unresectable hepatocellular carcinoma (HCC) eligible for embolization, typically producing a median progression-free survival of eight to ten months.